The Scientist

» clinical trials and disease/medicine

Most Recent

image: Your Body Is Teeming with Weed Receptors

Your Body Is Teeming with Weed Receptors

By | July 17, 2017

And the same endocannabinoid system that translates marijuana's buzz-inducing compounds into a high plays crucial roles in health and disease outside the brain.

2 Comments

image: Endocannabinoids in the Groove

Endocannabinoids in the Groove

By | July 17, 2017

The system responsible for the buzz humans get from marijuana plays a passel of physiological roles outside the brain.

0 Comments

In two early trials, vaccines tailored to the mutations in individuals’ cancers appeared to protect 12 of 19 patients against relapse. 

1 Comment

image: Anti-Preeclampsia Hormone Discovered

Anti-Preeclampsia Hormone Discovered

By | June 29, 2017

A small, placenta-produced peptide fixes the pregnancy-related condition in mice. 

1 Comment

image: Art’s Diagnosticians

Art’s Diagnosticians

By | June 12, 2017

Physicians peer into the subjects of artistic masterpieces, and find new perspective on their own approach to diagnosing maladies.

0 Comments

A new screening tool flags dozens of papers with potential errors.

0 Comments

The publicly available database found nearly a third of samples included mutations targeted by either approved drugs or therapies in clinical trials. 

0 Comments

The new findings, obtained from cell culture experiments, could explain the link between infection with the virus during pregnancy and infant microcephaly.

1 Comment

image: Micronutrients, Macro Impact

Micronutrients, Macro Impact

By | June 1, 2017

At the interface of food, nutrition, and agriculture, Lindsay Allen’s research has been informing nutrition guidelines and policies around the world for decades.

1 Comment

image: Pinpointing the Culprit

Pinpointing the Culprit

By | June 1, 2017

Identifying immune cell subsets with CyTOF

0 Comments

Popular Now

  1. GM Mosquitoes Closer to Release in U.S.
  2. Effects of Neanderthal DNA on Modern Humans
  3. Flux and Uncertainty in the CRISPR Patent Landscape
  4. Do Pathogens Gain Virulence as Hosts Become More Resistant?
RayBiotech